Korean J Intern Med.
2017 Jul;32(4):631-633. 10.3904/kjim.2017.209.
Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
- Affiliations
-
- 1Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. sekim@hallym.or.kr
- KMID: 2387707
- DOI: http://doi.org/10.3904/kjim.2017.209
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B
- Anti-viral Treatment of Chronic Hepatitis B
- Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
- New Potential Therapies for Chronic Hepatitis B
- Clinical Significance of Hepatitis B Surface Antigen Quantification in Chronic Hepatitis B
